Ardent Health (NYSE:ARDT) Price Target Cut to $12.00 by Analysts at Truist Financial

Ardent Health (NYSE:ARDT) had its price target decreased by Truist Financial from $13.00 to $12.00 in a research report released on Tuesday,Benzinga reports. Truist Financial currently has a buy rating on the stock.

ARDT has been the subject of several other research reports. Weiss Ratings reissued a “sell (d+)” rating on shares of Ardent Health in a report on Friday, June 12th. Royal Bank Of Canada decreased their price objective on Ardent Health from $13.00 to $12.00 and set an “outperform” rating on the stock in a research note on Thursday, July 9th. UBS Group boosted their price objective on Ardent Health from $13.00 to $13.50 and gave the company a “buy” rating in a research note on Thursday, May 7th. Wall Street Zen lowered shares of Ardent Health from a “buy” rating to a “hold” rating in a report on Sunday. Finally, Zacks Research raised shares of Ardent Health from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 25th. Seven equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, Ardent Health presently has an average rating of “Hold” and an average target price of $14.04.

Ardent Health Stock Down 2.3%

Shares of ARDT stock opened at $9.84 on Tuesday. The company has a current ratio of 2.12, a quick ratio of 2.00 and a debt-to-equity ratio of 0.62. Ardent Health has a 12 month low of $7.71 and a 12 month high of $15.48. The stock has a market cap of $1.41 billion, a P/E ratio of 10.36, a P/E/G ratio of 2.28 and a beta of 0.76. The company has a 50 day simple moving average of $9.60 and a two-hundred day simple moving average of $9.27.

Ardent Health (NYSE:ARDT) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.18 by $0.10. Ardent Health had a net margin of 2.09% and a return on equity of 13.85%. The business had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.58 billion. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. On average, research analysts expect that Ardent Health will post 1.1 earnings per share for the current year.

Insider Activity

In related news, CFO Alfred Lumsdaine bought 10,000 shares of the stock in a transaction dated Friday, June 5th. The shares were purchased at an average price of $8.81 per share, with a total value of $88,100.00. Following the completion of the acquisition, the chief financial officer owned 329,183 shares of the company’s stock, valued at $2,900,102.23. This represents a 3.13% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.90% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Ardent Health

A number of hedge funds have recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd raised its position in shares of Ardent Health by 1,177.7% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock valued at $25,000 after buying an additional 2,638 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank bought a new stake in Ardent Health during the 3rd quarter valued at about $61,000. Monetary Solutions Ltd bought a new stake in Ardent Health during the 4th quarter valued at $79,000. New York State Common Retirement Fund raised its holdings in shares of Ardent Health by 121.4% in the second quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock valued at $85,000 after acquiring an additional 3,400 shares in the last quarter. Finally, Abel Hall LLC purchased a new position in Ardent Health during the 1st quarter valued at about $87,000.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.